Equities researchers at William Blair issued their FY2028 earnings estimates for Tempest Therapeutics in a research report ...
Stock analysts at William Blair issued their Q1 2025 EPS estimates for Neurogene in a research report issued to clients and ...
Tesla Q1 deliveries may decline sharply amid weak Europe and China sales. Read more about TSLA stock here and why it is a ...
Friday - Analysts at William Blair have maintained a Market Perform rating on DocuSign Inc . (NASDAQ:DOCU) following the company’s fourth-quarter earnings release. With a market capitalization ...
Investor's Business Daily on MSN1h
Tesla Delivers 336,681 EVs, Below Views And Lowest In Years. Tesla Stock Reverses Higher. (Live Coverage)Tesla reported first-quarter vehicle deliveries of 336,681 before Wednesday's stock market open Wednesday. That was worse ...
Lululemon stock fell 15% in afternoon trading after CEO Calvin McDonald said consumers are beginning to spend less in ...
Artificial intelligence is already improving this business' financial results, but there could be a lot more to come.
Barchart on MSN12d
Stocks Fall on Disappointing Corporate Earnings and Economic WorriesThe S&P 500 Index ($SPX) (SPY) today is down -0.54%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.62%, and the ...
Shares of data-mining and analytics company Palantir (NYSE:PLTR) jumped 7% in the pre-market session after the company revealed new commercial customers, including Walgreens Boots Alliance and ...
Indian equities have of late come under pressure amid waning domestic consumption, raising questions over the outlook for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback